ID   RET981
AC   CVCL_VJ81
DR   Cosmic; 2539064
DR   Wikidata; Q98128914
RX   PubMed=9723034;
RX   PubMed=25316813;
ST   Source(s): PubMed=25316813
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D16S539: 9,12
ST   D5S818: 9,14
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8025; Malignant mixed tumor of the salivary gland
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
RX   PubMed=9723034; DOI=10.1016/S0165-4608(98)00013-2;
RA   Rao P.H., Murty V.V.V.S., Louie D.C., Chaganti R.S.K.;
RT   "Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant
RT   mixed tumor of salivary gland.";
RL   Cancer Genet. Cytogenet. 105:160-163(1998).
//
RX   PubMed=25316813; DOI=10.1158/1078-0432.CCR-14-1746; PMCID=PMC4268116;
RA   Mitani Y., Rao P.H., Maity S.N., Lee Y.-C., Ferrarotto R., Post J.C.,
RA   Licitra L., Lippman S.M., Kies M.S., Weber R.S., Caulin C., Lin S.-H.,
RA   El-Naggar A.K.;
RT   "Alterations associated with androgen receptor gene activation in
RT   salivary duct carcinoma of both sexes: potential therapeutic
RT   ramifications.";
RL   Clin. Cancer Res. 20:6570-6581(2014).
//